Evaluation of amotosalem treated platelets over 7 days of storage with an automated cytometry assay panel
Autor: | A. M. Tagliavia, G. De Francisci, M. Marcatti, Rosalia Agliastro, B. Palma, M. Diquattro, R. Bonaccorso |
---|---|
Rok vydání: | 2013 |
Předmět: |
Blood Platelets
Platelet Membrane Glycoprotein IIb Time Factors Fibrinogen receptor Clinical Biochemistry Biology Immunophenotyping Flow cytometry Andrology chemistry.chemical_compound Furocoumarins Lactate dehydrogenase medicine Humans Platelet Mean platelet volume Pathogen medicine.diagnostic_test Biochemistry (medical) Integrin beta3 Hematology General Medicine Flow Cytometry Phenotype Platelet transfusion chemistry Blood Preservation Immunology Cytometry |
Zdroj: | International Journal of Laboratory Hematology. 35:637-643 |
ISSN: | 1751-5521 |
DOI: | 10.1111/ijlh.12102 |
Popis: | Summary Introduction Pathogen Inactivation allows to overcome microbial contamination and growth related to storage of platelets concentrates (PC) at room temperature. The aim of our study was to evaluate the platelet storage lesion extending the storage period of pathogen inactivated platelet concentrates over 7 days using an automated cytometry assay panel. Methods We analyzed 43 concentrates subjected to pathogen inactivation (CPPI) at 3, 5 and 7 days evaluating: platelet count, mean platelet volume, platelets at low optical density, platelets at high density, GPIIb-IIIa glycoprotein, platelet microparticles, lactate dehydrogenase. The collection bags (Fenwal) and the IBS kit made in PL2410/PL2411 are approved for the conservation of PC up to 7 days. Data analysis was performed with anova test. Results All the parameters except small platelets and PMP were statistically different among day 7 vs. 3 and day 7 vs. 5. Conclusions Our study showed a progressive modification of pathogen inactivated platelet concentrates observed up to 7 days. The persistence of the secretory pool and the presence of the platelet membrane fibrinogen receptor suggest the persistence of a potential hemostatic efficacy. Clinical studies are necessary to directly correlate this type of analysis to 24 h recovery or survival of transfused platelets in humans. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |